Literature DB >> 6231928

Plasmin regulating system from embryonal carcinoma F9 cells: plasminases A, B and embrinogen.

V Keil-Dlouha, E Joukoff, T Planchenault.   

Abstract

Two plasmin inactivators, plasminase A and B, and their inhibitor embrinogen were isolated from embryonal carcinoma F9 cells by preparative two-dimensional electrophoresis. Plasminases A and B have molecular weights of 160,000 and 82,000, respectively. Both are serine proteinases which digest the light chain of plasmin in a time dependent inactivation process. The heavy chain of plasmin is not affected by this action. Plasminases A and B show similar specificity towards synthetic and natural polypeptide inhibitors. The interaction of the two enzymes leads to their inhibition. Embrinogen (m.w. 84,000) inhibits both plasminases A and B as well as urokinase and plasmin. Its activation by trypsin creates embrin, a proteinase directed against plasmin heavy chain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231928     DOI: 10.1016/s0006-291x(84)80315-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Potential proteolytic activity of human plasma fibronectin.

Authors:  V Keil-Dlouha; T Planchenault
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.